Nuveen Asset Management, LLC Pa Vmed Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $495,211 - $821,468	-582,602 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.16 - $2.5 $164,404 - $354,320	-141,728 Reduced 19.57%	582,602 $874,000
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $298,299 - $1.06 Million	-121,260 Reduced 14.34%	724,330 $2.07 Million
Q3 2021 Nov 12, 2021	SELL	$5.1 - $9.39 $1.92 Million - $3.53 Million	-375,492 Reduced 30.75%	845,590 $6.88 Million
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $3.99 Million - $6.95 Million	1,009,979 Added 478.43%	1,221,082 $7.82 Million
Q1 2021 May 17, 2021	BUY	$2.01 - $5.55 $55,345 - $152,819	27,535 Added 15.0%	211,103 $937,000
Q4 2020 Feb 16, 2021	SELL	$1.73 - $2.13 $1,250 - $1,539	-723 Reduced 0.39%	183,568 $389,000
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.65 $322,509 - $488,371	184,291 New	184,291 $389,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $106M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.